Lisa Gill
Stock Analyst at JP Morgan
(3.21)
# 1,028
Out of 4,862 analysts
136
Total ratings
47.73%
Success rate
1.56%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Overweight | $29 → $32 | $22.64 | +41.34% | 5 | May 28, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $525 → $405 | $313.53 | +29.17% | 7 | May 15, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $180 → $190 | $180.21 | +5.43% | 3 | May 6, 2025 | |
| CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $21.45 | +39.86% | 2 | Mar 19, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $31.60 | +29.75% | 4 | Mar 6, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $14.94 | +13.79% | 4 | Mar 6, 2025 | |
| HUM Humana | Maintains: Neutral | $257 → $256 | $235.26 | +8.82% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $67.46 | +20.07% | 5 | Feb 18, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $142 → $145 | $161.41 | -10.17% | 6 | Feb 4, 2025 | |
| COR Cencora | Maintains: Overweight | $289 → $301 | $295.54 | +1.85% | 2 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $10.32 | +74.42% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $3.56 | +40.45% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $22.73 | +23.19% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $15 | $11.39 | +31.69% | 14 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $6.86 | +31.20% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $22 → $18 | $7.79 | +131.07% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $728.20 | -9.23% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $317.40 | +38.00% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $13.15 | +36.88% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $298.14 | +32.49% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $261.12 | -6.94% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $171.07 | +8.73% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $164.37 | -14.83% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $371.18 | -10.56% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $628 → $631 | $384.55 | +64.09% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.37 | +128.83% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $2.15 | +318.60% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $4.92 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $5.26 | +52.09% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $70.19 | +18.25% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $55.22 | +77.47% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $22.57 | - | 4 | Dec 19, 2017 |
Privia Health Group
May 28, 2025
Maintains: Overweight
Price Target: $29 → $32
Current: $22.64
Upside: +41.34%
UnitedHealth Group
May 15, 2025
Maintains: Overweight
Price Target: $525 → $405
Current: $313.53
Upside: +29.17%
Quest Diagnostics
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $180.21
Upside: +5.43%
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $21.45
Upside: +39.86%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $31.60
Upside: +29.75%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $14.94
Upside: +13.79%
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $235.26
Upside: +8.82%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $67.46
Upside: +20.07%
Cardinal Health
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $161.41
Upside: -10.17%
Cencora
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $295.54
Upside: +1.85%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $10.32
Upside: +74.42%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $3.56
Upside: +40.45%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $22.73
Upside: +23.19%
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $11.39
Upside: +31.69%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $6.86
Upside: +31.20%
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $7.79
Upside: +131.07%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $728.20
Upside: -9.23%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $317.40
Upside: +38.00%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $13.15
Upside: +36.88%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $298.14
Upside: +32.49%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $261.12
Upside: -6.94%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $171.07
Upside: +8.73%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $164.37
Upside: -14.83%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $371.18
Upside: -10.56%
May 30, 2024
Maintains: Overweight
Price Target: $628 → $631
Current: $384.55
Upside: +64.09%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.37
Upside: +128.83%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $2.15
Upside: +318.60%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $4.92
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $5.26
Upside: +52.09%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $70.19
Upside: +18.25%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $55.22
Upside: +77.47%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $22.57
Upside: -